Holen Sie sich die Stockscreener-App
5.67
5.03%
-0.30
Schlusskurs vom Vortag:
$5.97
Offen:
$5.805
24-Stunden-Volumen:
14,121
Relative Volume:
0.26
Marktkapitalisierung:
$8.44M
Einnahmen:
$57.92M
Nettoeinkommen (Verlust:
$-31.14M
KGV:
-1.0193
EPS:
-5.5628
Netto-Cashflow:
$-19.56M
1W Leistung:
-4.55%
1M Leistung:
+56.20%
6M Leistung:
-43.72%
1J Leistung:
-87.93%
1-Tages-Spanne:
$5.60
$5.89
1-Wochen-Bereich:
$5.60
$7.30
52-Wochen-Spanne:
$2.5211
$61.00
Dna X Inc Stock (SONM) Company Profile
Firmenname
Dna X Inc
Sektor
Branche
Telefon
650-378-8100
Adresse
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
5.67 | 8.88M | 57.92M | -31.14M | -19.56M | -5.5628 |
|
MSFT
Microsoft Corporation
|
401.32 | 2.98T | 305.45B | 119.26B | 77.41B | 15.98 |
|
ORCL
Oracle Corp
|
160.14 | 449.74B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
PLTR
Palantir Technologies Inc
|
131.41 | 307.77B | 4.48B | 1.63B | 2.10B | 0.6363 |
|
CRWD
Crowdstrike Holdings Inc
|
429.64 | 103.75B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
437.09 | 80.99B | 7.05B | 1.34B | 1.35B | 8.0234 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-31 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-09 | Hochstufung | National Securities | Neutral → Buy |
| 2019-06-10 | Eingeleitet | National Securities | Neutral |
| 2019-06-04 | Eingeleitet | Lake Street | Buy |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Dna X Inc Aktie (SONM) Neueste Nachrichten
Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS
Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks
DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka
Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY
Sonim Technologies Sees Executive Departures and New Board Appointment - TipRanks
Leadership shake-up at DNA X (NASDAQ: SONM) as CEO exits and investor designee joins board - Stock Titan
DNA X, Inc. Announces Management Changes - marketscreener.com
Will Sonim Technologies Inc. stock outperform value stocksJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - mfd.ru
Best Tech Penny Stocks Right Now • Updated Daily - Benzinga
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - IT Business Net
Five reasons to go rugged in public safety: Sonim Technologies on building phones for fireground realties - International Fire & Safety Journal
Sonim Technologies rebrands as DNA X following asset sale to NEXA - Investing.com Nigeria
Sonim Technologies Rebrands as DNA X, Shifts Strategy - TipRanks
DNA X Signs Asset Purchase Agreement Amendment and Terminates Streeterville Notes - TradingView
Sonim sells assets, rebrands as DNA X running digital asset platform - stocktitan.net
EPS Watch: Is Sonim Technologies Inc exposed to currency risksMarket Trend Review & Entry Point Confirmation Signals - baoquankhu1.vn
Market Wrap: Is Sonim Technologies Inc affected by consumer sentimentWeekly Stock Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Sonim Technologies : NEXA Completes Acquisition of Sonim - marketscreener.com
Sonim Technologies : News Release - marketscreener.com
Sonim Technologies (SONM) Projected to Post Earnings on Friday - Defense World
Volatility Watch: Should value investors consider Sonim Technologies IncWeekly Trade Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Sentiment Review: What is the Moat Score of Sonim Technologies IncJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Portfolio Recap: What are the risks of holding Sonim Technologies IncJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Whats the fair value of Sonim Technologies Inc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Resistance Check: Will Sonim Technologies Inc benefit from seasonalityWeekly Trade Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products - Business Wire
Quarterly Trades: Is Sonim Technologies Inc affected by consumer sentimentWeekly Trend Recap & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Inflation Data: Can Sonim Technologies Inc stock hit analyst price targets2025 Key Highlights & Reliable Intraday Trade Plans - Bộ Nội Vụ
Options Flow: Will Sonim Technologies Inc stock outperform tech sector in 2025Stop Loss & Low Risk Growth Stock Ideas - Bộ Nội Vụ
Inflation Data: Will Sonim Technologies Inc. stock outperform tech sector in 2025Treasury Yields & Daily Entry Point Trade Alerts - Bộ Nội Vụ
VIX Spike: Why Sonim Technologies Inc. stock is favored by top institutionsProfit Target & Daily Volume Surge Trade Alerts - Bộ Nội Vụ
Is Sonim Technologies Inc. (6RO) stock overpriced at current multiplesChart Signals & Low Drawdown Trading Strategies - ulpravda.ru
Loss Report: How Sonim Technologies Inc stock performs in weak economyWeekly Stock Recap & Daily Entry Point Trade Alerts - Bộ Nội Vụ
Will Sonim Technologies Inc. (2W9) stock boost dividends further2025 Investor Takeaways & High Yield Stock Recommendations - Улправда
Can Sonim Technologies Inc. stock maintain growth trajectoryEarnings Overview Summary & Accurate Buy Signal Alerts - Улправда
Market Recap: How rising interest rates impact Sonim Technologies Inc. stock2025 Market WrapUp & AI Powered Buy and Sell Recommendations - Улправда
How rising interest rates impact Sonim Technologies Inc. stockQuarterly Portfolio Summary & Precise Trade Entry Recommendations - Улправда
How Sonim Technologies Inc. stock valuations compare to rivalsMomentum Trading Signals & Market Trend Real-Time Reports - ulpravda.ru
Sonim stockholders approve sale of rugged device business to NEXA By Investing.com - Investing.com Australia
Sonim Technologies Stockholders Approve Asset Sale to NEXA, Clearing Path for Strategic Transition - TradingView — Track All Markets
Sonim Technologies shareholders approve asset sale to Pace Car Acquisition By Investing.com - Investing.com Nigeria
Sonim Technologies shareholders approve asset sale to Pace Car Acquisition - Investing.com
What's Driving the Market Sentiment Around Sonim Technologies Inc? - Benzinga
12 Information Technology Stocks Moving In Wednesday's Intraday Session - Benzinga
Why Sonim Technologies Inc. stock is favored by top institutions2025 Volume Leaders & Safe Entry Zone Tips - Улправда
Geopolitics Watch: Will Sonim Technologies Inc. (6RO) stock beat value stocksWeekly Market Report & Stock Portfolio Risk Control - Улправда
Bear Alert: How Sonim Technologies Inc. stock reacts to oil pricesJuly 2025 Outlook & AI Forecasted Stock Moves - moha.gov.vn
How Sonim Technologies Inc. stock reacts to job market dataWeekly Volume Report & Risk Controlled Daily Trade Plans - Улправда
How geopolitical risks impact Sonim Technologies Inc. (2W9) stock2025 Market Overview & AI Driven Price Predictions - Улправда
Is Sonim Technologies Inc. stock a buy for dividend growth2025 Big Picture & Momentum Based Trading Signals - Улправда
Breakout Move: Will Sonim Technologies Inc. (6RO) stock beat value stocksWeekly Investment Report & Capital Efficiency Focused Ideas - Улправда
Finanzdaten der Dna X Inc-Aktie (SONM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dna X Inc-Aktie (SONM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 10% Owner |
Jun 30 '25 |
Sale |
1.39 |
400,514 |
556,714 |
0 |
| Becher Charles | See Remarks |
Apr 23 '25 |
Sale |
1.45 |
31,326 |
45,423 |
62,668 |
| MULICA MICHAEL C | Director |
Apr 23 '25 |
Sale |
1.45 |
27,818 |
40,336 |
73,292 |
| Crolius Clayton | Chief Financial Officer |
Apr 23 '25 |
Sale |
1.45 |
11,634 |
16,869 |
30,958 |
| Cassano James S | Director |
Apr 23 '25 |
Sale |
1.45 |
23,381 |
33,902 |
49,126 |
| Wang Jeffrey | Director |
Apr 23 '25 |
Sale |
1.45 |
4,478 |
6,493 |
21,301 |
| Steenstra Jack | Director |
Apr 23 '25 |
Sale |
1.45 |
23,381 |
33,902 |
49,139 |
3.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):